Declining blood lead and zinc protoporphyrin levels in Ecuadorian Andean children

Clinical Biochemistry

Volumn 46, Issue 13-14, 2013, Pages 1233-1238

  Ortega, Fernando ^a   Counter, S Allen ^b,c   Buchanan, Leo H ^d,e   Coronel Parra, Angelica M ^f   Collaguaso, Maria Angela ^f   Jacobs, Anthony B ^e   Rifai, Nader ^b,g   Hoover, Patricia Nolan ^g  

^a UNIVERSIDAD SAN FRANCISCO DE QUITO   (Ecuador)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e HARVARD UNIVERSITY   (United States)

^f La Concordia   (Ecuador)

^g BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Andes; Blood; Children; Lead; Zinc protoporphyrin

Indexed keywords

BIOLOGICAL MARKER; LEAD; PROTOPORPHYRIN ZINC; HEME; PROTOPORPHYRIN;

ADOLESCENT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CHELATION THERAPY; CHILD; CHILDHOOD INJURY; CLINICAL ARTICLE; COHORT ANALYSIS; CORRELATION ANALYSIS; ECUADOR; FEMALE; HEALTH EDUCATION; HEAVY METAL POISONING; HUMAN; INFANT; LEAD BLOOD LEVEL; LEAD POISONING; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; BLOOD; METABOLISM; OCCUPATIONAL EXPOSURE; TOXICITY;

CHILD; ECUADOR; FEMALE; HEME; HUMANS; LEAD; LEAD POISONING; MALE; OCCUPATIONAL EXPOSURE; PROTOPORPHYRINS;

EID: 84882811191     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.05.002     Document Type: Article

References (28)

1. Fewtrell L.J., Prüss-Ustün A., Landrigan P., Ayuso-Mateos J.L. Estimating the global burden of disease of mild mental retardation and cardiovascular diseases from environmental lead exposure. Environ Res 2004, 94:120-133.
2. Dissanayake V., Erickson T.B. Ball and chain: the global burden of lead poisoning. Clin Toxicol 2012, 50:528-531.
3. Caravanos J., Chatham-Stephens K., Ericson B., Landrigan P.J., Fuller R. The burden of disease from pediatric lead exposure at hazardous waste sites in 7 Asian countries. Environ Res 2012, [Epub ahead of print]. 10.1016/j.envres.2012.06.006.
4. Lalor G., Rattray R., Vutchkov M., Campbell B., Lewis-Bell K. Blood lead levels in Jamaican school children. Sci Total Environ 2001, 269:171-181.
5. Safi J., Fischbein A., El Haj S., Sansour R., Jaghabir M., Hashish M.A., et al. Childhood lead exposure in the Palestinian Authority, Israel, and Jordan: results from the Middle Eastern regional cooperation project, 1996-2000. Environ Health Perspect 2006, 114:917-922.
6. Wang S., Zhang J. Blood lead levels in children, China. Environ Res 2006, 101:412-418.
7. Koller K., Brown T., Spurgeon A., Levy L. Recent developments in low-level lead exposure and intellectual impairment in children. Environ Health Perspect 2004, 112:987-994.
8. Lanphear B.P., Hornung R., Khoury J., Yolton K., Baghurst P., Bellinger D.C., et al. Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect 2005, 113:894-899.
9. Binns H.J., Campbell C., Brown M.J. Interpreting and managing blood lead levels of less than 10microg/dL in children and reducing childhood exposure to lead: recommendations of the Centers for Disease Control and Prevention Advisory Committee on Childhood Lead Poisoning Prevention. Pediatrics 2007, 120:1285-1298.
10. ATSDR Toxicological profile for lead 2007, US Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta, GA.
11. Bergdahl I.A., Grubb A., Schütz A., Desnick R.J., Wetmur J.G., Sassa S., et al. Lead binding to delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes. Pharmacol Toxicol 1997, 81:153-158.
12. Barbosa F., Tanus-Santos J.E., Gerlach R.F., Parsons P.J. A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs. Environ Health Perspect 2005, 113:1669-1674.
13. Rettmer R.L., Carlson T.H., Origenes M.L., Jack R.M., Labb R.F. Zinc protoporphyrin/heme ratio for diagnosis of preanemic iron deficiency. Pediatrics 1999, 104:1-5.
14. Froom P., Kristal-Boneh E., Benbassat J., Ashkanazi R., Ribak J. Predictive value of determinations of zinc protoporphyrin for increased blood lead concentrations. Clin Chem 1998, 44:1283-1288.
15. Martin C.J., Werntz C.L., Ducatman A.M. The interpretation of zinc protoporphyrin changes in lead intoxication: a case report and review of the literature. Occup Med 2004, 54:587-591.
16. Crowell R., Ferris A.M., Wood R.J., Joyce P., Slivka H. Comparative effectiveness of zinc protoporphyrin and hemoglobin concentrations in identifying iron deficiency in a group of low-income, preschool-aged children: practical implications of recent illness. Pediatrics 2006, 118:224-232.
17. Counter S.A., Buchanan L.H., Ortega F., Laurell G. Normal auditory brainstem and cochlear function in extreme pediatric plumbism. J Neurol Sci 1997, 152:85-92.
18. Counter S.A., Buchanan L.H., Ortega F., Amarisiriwardena C., Hu H. Environmental lead contamination and pediatric lead intoxication in an Ecuadorian Andean Village. Int J Occup Environ Health 2000, 6:169-176.
19. Counter S.A., Buchanan L.H., Ortega F., Rifai N. Blood lead and hemoglobin levels in Andean children with chronic lead intoxication. Neurotoxicology 2000, 21:301-308.
20. Counter S.A., Buchanan L.H., Ortega F. Current pediatric and maternal lead levels in blood and breast milk in Andean inhabitants of a lead-glazing enclave. J Occup Environ Med 2004, 46:967-973.
21. Counter S.A., Buchanan L.H., Ortega F., Rifai N., Shannon M.W. Comparative analysis of zinc protoporphyrin and blood lead levels in lead-exposed Andean children. Clin Biochem 2007, 40:787-792.
22. Counter S.A., Buchanan L.H., Ortega F. Zinc protoporphyrin levels, blood lead levels and neurocognitive deficits in Andean children with chronic lead exposure. Clin Biochem 2008, 41:41-47.
23. Counter S.A., Buchanan L.H., Ortega F., Rosas H.D. Neurocognitive effects of elevated blood lead levels in Andean children. J Neurol Sci 1998, 160:47-53.
24. Counter S.A., Buchanan L.H., Ortega F. Neurocognitive impairment in lead-exposed children of Andean lead-glazing workers. J Occup Environ Med 2005, 47:306-312.
25. Counter S.A., Buchanan L.H., Ortega F. Lead concentrations in maternal blood and breast milk and pediatric blood of Andean villagers: 2006 follow-up investigation. J Occup Environ Med 2007, 49:302-309.
26. Counter S.A., Ortega F., Shannon M.W., Buchanan L.H. Succimer (meso-2,3-dimercaptosuccinic acid (DMSA) treatment of Andean children with environmental lead exposure. Int J Occup Environ Health 2003, 9:164-168.
27. Counter S.A., Buchanan L.H., Ortega F. Neurophysiologic and neurocognitive case profiles of Andean patients with chronic environmental lead poisoning. J Toxicol Environ Health A 2009, 72:1150-1159.
28. Vahter M., Counter S.A., Laurell G., Buchanan L.H., Ortega F., Schütz A., et al. Extensive lead exposure in children living in an area with production of lead-glazed tiles in the Ecuadorian Andes. Int Arch Occup Environ Health 1997, 70:282-286.